US 11472888
Reelin antibodies for treatment of atherosclerosis
granted A61KA61K2039/505A61K31/713
Quick answer
US patent 11472888 (Reelin antibodies for treatment of atherosclerosis) held by The Board of Regents of the University of Texas System expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K31/713, A61K38/00, A61K45/06